| Case report: re-treatment with lu-dotatate in neuroendocrine tumors EM Vida Navas, A Martínez Lorca, A Sancho Gutiérrez, L Sanz Gomez, ... Frontiers in Endocrinology 12, 676973, 2021 | 1 | 2021 |
| 6P Clinical and molecular characteristics in non-small cell lung cancer patients with alteration in PIK3 pathway Y Lage, PÁ Ballesteros, MEO García, AG Rueda, EC de la Fuente, ... Journal of Thoracic Oncology 16 (4), S701, 2021 | 1 | 2021 |
| Treatment of metastatic squamous cell carcinoma arising in sacrococcygeal pilonidal sinus: a case report series A Soria Rivas, S Bea-Ardebol, E Vida Navas, ÓM Muñoz-Arrones, ... Frontiers in Medicine 10, 1248894, 2023 | | 2023 |
| 1117P Mutational landscape of large cell neuroendocrine lung carcinoma: Molecular characterization using next generation sequencing M San Roman-Gil, L Sanz-Gómez, J Chamorro-Pérez, Y Lage, ... Annals of Oncology 32, S918-S919, 2021 | | 2021 |
| Compresión medular por metástasis de melanoma JE Villarrubia, JT Jiménez, PÁ Ballesteros, IO Martín, LS Gómez, ... Medicina Clínica Práctica 4 (3), 100183, 2021 | | 2021 |
| 125P Benefit of immunotherapy in advanced NSCLC patients selected by KRAS mutations: A single institute retrospective analysis JJS Castillo, EC de la Fuente, MEO García, AG Rueda, Y Lage, ... Journal of Thoracic Oncology 16 (4), S765-S766, 2021 | | 2021 |
| 124P KRAS mutated (mt) non-small cell lung cancer (NSCLC) and response to antiPD-1/PD-L1 regarding co-mutational status and assessment of KRAS mutation on plasma or tissue biopsy EC de la Fuente, JJS Castillo, AG Rueda, Y Lage, MEO García, ... Journal of Thoracic Oncology 16 (4), S765, 2021 | | 2021 |
| 52P Genetic and clinical profiling of a cohort of extended small cell lung carcinoma EMV Navas, JC Pérez, EC de la Fuente, Y Lage, AG Rueda, JT Jiménez, ... Journal of Thoracic Oncology 16 (4), S724, 2021 | | 2021 |
| 218P Clinical characteristics and treatment outcomes in lung cancer patients with FGFR genes alterations JT Jiménez, JE Villarrubia, EMV Navas, JJS Castillo, LS Gómez, IO Martín, ... Journal of Thoracic Oncology 16 (4), S814, 2021 | | 2021 |
| Benefit of immunotherapy in advanced NSCLC patients selected by KRAS mutations: A single institute retrospective analysis JJ Soto Castillo, E Corral de la Fuente, ME Olmedo Garcia, ... JOURNAL OF THORACIC ONCOLOGY 16 (4), S765-S766, 2021 | | 2021 |
| KRAS mutated (mt) non-small cell lung cancer (NSCLC) and response to antiPD-1/PD-L1 regarding co-mutational status and assessment of KRAS mutation on plasma or tissue biopsy E Corral de la Fuente, JJ Soto Castillo, A Gomez Rueda, Y Lage, ... JOURNAL OF THORACIC ONCOLOGY 16 (4), S765-S765, 2021 | | 2021 |
| 1744P COVID-19 in cancer patients: Risk factors for the development of severe clinical event (SCE) JJS Domingo, EC de la Fuente, RM Huertas, EMV Navas, JJS Castillo, ... Annals of Oncology 31, S1019, 2020 | | 2020 |
| Massive Hiatal Hernia after Total Gastrec-tomy LS Gómez, JE Villarrubia, EV Navas, JJS Castillo, JT Jiménez Ann Case Report 5, 534, 2020 | | 2020 |
